Literature DB >> 35178985

[New eudesmane sesquiterpenoids from Atractylodis Macrocephalae Rhizoma and their inhibitory activities against SREBPs].

Rui-Zhu Xu1, Xuan Zhao2, Yue-Yue DU1, Meng-Sha Xu2, Xin-Guang Liu3, Zhi-Shen Xie3, Song Gao4, Jiang-Yan Xu3, Pan Wang5.   

Abstract

Three sesquiterpenoids were isolated and purified from the 95% ethanol extract of Atractylodis Macrocephalae Rhizoma by column chromatography on silica gel, Sephadex LH-20, ODS, and high-performance liquid chromatography(HPLC). Their chemical structures were identified on the basis of spectroscopic analysis and physiochemical properties as(7Z)-8β,13-diacetoxy-eudesma-4(15),7(11)-diene(1), 7-oxo-7,8-secoeudesma-4(15),11-dien-8-oic acid(2), and guai-10(14)-en-11-ol(3). Compounds 1 and 2 are new compounds and compound 3 was obtained from Compositae family for the first time. Compounds 1, 2, and 3 showed weak inhibitory activities against sterol regulatory element-binding proteins(SREBPs).

Entities:  

Keywords:  Atractylodis Macrocephalae Rhizoma; SREBPs inhibitor; chemical constituent; sesquiterpenoid

Mesh:

Substances:

Year:  2022        PMID: 35178985     DOI: 10.19540/j.cnki.cjcmm.20211014.201

Source DB:  PubMed          Journal:  Zhongguo Zhong Yao Za Zhi        ISSN: 1001-5302


  1 in total

1.  [Exploration of the therapeutic mechanism of Yiqi Jiedu recipe for treatment of primary liver cancer based on network pharmacology and molecular docking].

Authors:  M Xu; P Zhang; G Zhang
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2022-06-20
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.